Observational studyAnnals of hematology2025

Final results on effectiveness and safety of Ibrutinib in patients with chronic lymphocytic leukemia from the non-interventional FIRE study.

Caroline Dartigeas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.